Advice You - Internet and Businesses Online

Off the Web, mail marketing is hated by customers. It’s unwanted, uninvited and stuffs mail boxes. But i

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

t’s pretty clear that it’s also incredibly popular with advertisers. Why? Because while most potential c

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

stomers toss away their junk letters with barely a glance, enough take action to make it all worthwhile.

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

They do buy—and in high enough numbers to more than cover the cost of those who don’t.

Email marketing

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s pretty similar, but with one important difference: on the Web, you can only send marketing emails to p

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

eople who have already chosen to receive them. A bit tricky. On the other hand, because those people hav

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

already chosen to receive your emails, you can be confident that they’re going to buy.

Email is still

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

he most popular and most used application on the Internet. It’s also an efficient means of distributing

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

our message to large numbers of people who have requested that information. As a form of marketing, it g

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

enerates high response rates—and gives you measurable results with instant feedback.

But because email

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

arketing been so abused, it’s just not accepted any more to send emails to people who haven’t chosen to

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

eceive them. Bust that rule, and there’s a good chance you’ll be out of business. That gives you the pro

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

lem of building up a list of willing subscribers.

When you’re first starting out, there’s often a tempt

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ation to simply purchase an opt-in email list. Lots of people sell them and you can easily pick up a mil

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ion or so addresses for just a few bucks. But while that may appear to be a fast, easy way to build up c

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

stomers, the names on the list may not be up to date, or even opt-in contacts at all. You could well fin

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

yourself inadvertently spamming.

Similarly, there are also programs that surf the Net, recording every

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

email address they find. These will let you quickly build up a huge list of e-mail addresses—none of wh

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

se owners will thank you when you stuff their inboxes with marketing material. Forget about them; they’r

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

not worth the effort. It’s much safer, and much more effective, to take the time to build your own list

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/62049/adviceyou-Online-Business---Collecting-OptIn-Email-Addresses.html">Online Business - Collecting Opt-In Email Addresses</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/62049/adviceyou-Online-Business---Collecting-OptIn-Email-Addresses.html]Online Business - Collecting Opt-In Email Addresses[/url]

If you're setting up a medical billing company and you're trying to decide between NSF 3.01 and UB-92 for your electronic claims transmission, the following article should give you some insight into the advantages of each.

Is your organization up to its eyeballs in bills? This article shows you how to implement Six Sigma as a cost cutting tool, in all types of organizations.

What you need to know before developing an effective brand identity. Don't begin your branding campaign blindly. Branding is much more than just a thoughtful logo or slogan. It's more than just a unique color scheme. There are steps that need to be taken in order to start your successful brand image.

Tags

Links

Advice You - Online Business - Collecting Opt-In Email Addresses

Related Articles: